Increase of oxidized/total coenzyme Q-10 ratio in cerebrospinal fluid in patients with Parkinson’s disease

Chronic systemic pesticide exposure reproduces features of Parkinson's disease

Betarbet, R., Sherer, T., Mackenzie, G., Garcia-Osuna, M., Panov, A., & Greenamyre, J. (2000) · Nature Neuroscience · doi:10.1038/81834 · Cited by 3,797 · see citing works

Mitochondrial Complex I Deficiency in Parkinson's Disease

Schapira, A. H. V., Cooper, J. M., Dexter, D., Clark, J. B., Jenner, P., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb02325.x · Cited by 2,283 · see citing works

Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase

Shimura, H., Hattori, N., Kubo, S.-I., Mizuno, Y., Asakawa, S., Minoshima, S., Shimizu, N., Iwai, K., Chiba, T., Tanaka, K., et al. (2000) · Nature Genetics · doi:10.1038/77060 · Cited by 2,024 · see citing works

Effects of Coenzyme Q10 in Early Parkinson Disease: Evidence of Slowing of the Functional Decline

Shults, C. W. (2002) · Archives of Neurology · doi:10.1001/archneur.59.10.1541 · Cited by 984 · see citing works

Coenzyme Q₁₀ levels correlate with the activities of complexes I and II/III in mitochondria from parkinsonian and nonparkinsonian subjects

Shults, C. W., Haas, R. H., Passov, D., & Beal, M. F. (1997) · Annals of Neurology · doi:10.1002/ana.410420221 · Cited by 326 · see citing works

Biomedical and clinical aspects of coenzyme Q

Littarru, G. P. (1993) · Journal of Molecular Medicine · doi:10.1007/bf00184478 · Cited by 310 · see citing works

Immunohistochemical studies on complexes I, II, III, and IV of mitochondria in parkinson's disease

Hattori, N., Tanaka, M., Ozawa, T., & Mizuno, Y. (1991) · Annals of Neurology · doi:10.1002/ana.410300409 · Cited by 275 · see citing works

Simultaneous Detection of Ubiquinol and Ubiquinone in Human Plasma as a Marker of Oxidative Stress

Yamashita, S., & Yamamoto, Y. (1997) · Analytical Biochemistry · doi:10.1006/abio.1997.2187 · Cited by 220 · see citing works

(E)-4-Hydroxy-2-Nonenal May be Involved in the Pathogenesis of Parkinson’s Disease

Selley, M. L. (1998) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(98)00021-5 · Cited by 215 · see citing works

An immunohistochemical study on α‐ketoglutarate dehydrogenase complex in Parkinson's disease

Mizuno, Y., Matuda, S., Yoshino, H., Mori, H., Hattori, N., & Ikebe, S. (1994) · Annals of Neurology · doi:10.1002/ana.410350212 · Cited by 199 · see citing works

Mitochondrial permeability transition mediates apoptosis induced by N‐methyl(R)salsolinol, an endogenous neurotoxin, and is inhibited by Bcl‐2 and rasagiline, N‐propargyl‐1(R)‐aminoindan

Akao, Y., Maruyama, W., Shimizu, S., Yi, H. L., Nakagawa, Y., Shamoto‐Nagai, M., Youdim, M. B. H., Tsujimoto, Y., & Naoi, M. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01047.x · Cited by 166 · see citing works

Ubiquinone (Coenzyme Q10) and Mitochondria in Oxidative Stress of Parkinson’s Disease

Ebadi, M., Govitrapong, P., Sharma, S., Muralikrishnan, D., Shavali, S., Pellett, L. J., Schafer, R., Albano, C. B., & Eken, J. (2001) · Neurosignals · doi:10.1159/000046889 · Cited by 150 · see citing works

Biomedical and clinical aspects of coenzyme Q

Cooper, M., & Clark, J. B. (1987) · Clinica Chimica Acta · doi:10.1016/0009-8981(87)90116-1 · Cited by 128 · see citing works

Superoxide-dependent depletion of reduced glutathione by L-DOPA and dopamine. Relevance to Parkinsonʼs disease

Spencer, J. P. E., Jenner, P. G., & Halliwell, B. B. (1995) · Neuroreport · doi:10.1097/00001756-199507310-00004 · Cited by 88 · see citing works

Issues in the early diagnosis of Parkinson's disease

Koller, W. C., & Montgomery, E. B. (1997) · Neurology · doi:10.1212/wnl.49.1_suppl_1.s10 · Cited by 65 · see citing works

High-performance liquid chromatography of coenzyme Q-related compounds and its application to biological materials

OKAMOTO, T., Fukui, K., NAKAMOTO, M., Kishi, T., Okishio, T., Yamagami, T., KANAMORI, N., Kishi, H., & Hiraoka, E. (1985) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(00)84487-4 · Cited by 60 · see citing works

Serum levels of coenzyme Q10 in patients with Parkinson's disease

Jiménez‐Jiménez, F. J., Molina, J. A., de Bustos, F., García‐Redondo, A., Gómez-Escalonilla, C., Martínez‐Salio, A., Berbel, Á., Camacho, A., Zurdo, M., Barcenilla, B., et al. (2000) · Journal of Neural Transmission · doi:10.1007/s007020050015 · Cited by 50 · see citing works

Genetic Epidemiology of Parkinson's Disease

Payami, H., & Zareparsi, S. (1998) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/089198879801100207 · Cited by 49 · see citing works

Potential neurotoxic “agents provocateurs” in Parkinson's disease

Collins, M. A., & Neafsey, E. J. (2002) · Neurotoxicology and Teratology · doi:10.1016/s0892-0362(02)00210-6 · Cited by 36 · see citing works

Coenzyme Q10 in Early Parkinson Disease

Hunter, D. A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.8.1170-a · Cited by 33 · see citing works

FORMATION OF LIPID HYDROPEROXIDES IN THE CUPRIC ION-INDUCED OXIDATION OF PLASMA AND LOW DENSITY LIPOPROTEIN

Yamamoto, Y., Kawamura, M., Tatsuno, K., Yamashita, S., Niki, E., & NAITO, C. (1991) · Elsevier eBooks · doi:10.1016/b978-0-08-041749-3.50055-3 · Cited by 30 · see citing works

Mitochondrial Approaches for Neuroprotection

Chaturvedi, R. K., & Beal, M. F. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.027 · Cited by 294 · see citing works

Therapeutic effects of coenzyme Q 10 (CoQ 10 ) and reduced CoQ 10 in the MPTP model of Parkinsonism

Cléren, C., Yang, L., Lorenzo, B. J., Calingasan, N. Y., Schomer, A. C., Sireci, A. N., Wille, E. J., & Beal, M. F. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05097.x · Cited by 158 · see citing works

Levels of reduced and oxidized coenzymeQ-10 and 8-hydroxy-2′-deoxyguanosine in the cerebrospinal fluid of patients with living Parkinson's disease demonstrate that mitochondrial oxidative damage and/or oxidative DNA damage contributes to the neurodegenerative process

Isobe, C., Abe, T., & Terayama, Y. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.11.065 · Cited by 130 · see citing works

The uptake and distribution of coenzyme Q(10)

Miles, M. V. (2007) · Mitochondrion · doi:10.1016/j.mito.2007.02.012 · Cited by 126 · see citing works

Cerebrospinal fluid biomarkers for Parkinson's disease - a systematic review

Andersen, A. D., Binzer, M., Stenager, E., & Gramsbergen, J. B. (2016) · Acta Neurologica Scandinavica · doi:10.1111/ane.12590 · Cited by 116 · see citing works

Randomized, double-blind, placebo-controlled pilot trial of reduced coenzyme Q10 for Parkinson's disease

Yoritaka, A., Kawajiri, S., Yamamoto, Y., Nakahara, T., Ando, M., Hashimoto, K., Nagase, M., Saito, Y., & Hattori, N. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.05.022 · Cited by 94 · see citing works

Cerebrospinal fluid biochemical studies in patients with Parkinson's disease: toward a potential search for biomarkers for this disease

Jiménez-Jiménez, F. J., Alonso‐Navarro, H., García‐Martín, E., & Agúndez, J. A. G. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00369 · Cited by 83 · see citing works

Periodontitis is associated with altered plasma fatty acids and cardiovascular risk markers

Ramírez-Tortosa, M. C., Quiles, J. L., Battino, M. A., Granados-Principal, S. M., Morillo, J. M., Bompadre, S., Newman, H. N., & Bullón, P. (2009) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2009.03.003 · Cited by 78 · see citing works

Coenzyme Q and Its Role in the Dietary Therapy against Aging

Varela-López, A., Giampieri, F., Battino, M., & Quiles, J. (2016) · Molecules · doi:10.3390/molecules21030373 · Cited by 86 · see citing works

Ferroptosis as a Major Factor and Therapeutic Target for Neuroinflammation in Parkinson’s Disease

Ko, C.-J., Gao, S.-L., Lin, T.-K., Chu, P.-Y., & Lin, H.-Y. (2021) · Biomedicines · doi:10.3390/biomedicines9111679 · Cited by 54 · see citing works

Oxidative stress-related biomarkers in Parkinson’s disease: A systematic review and meta-analysis

Khan, Z. H., & Ali, S. A. (2019) · Current Journal of Neurology · doi:10.18502/ijnl.v17i3.373 · Cited by 52 · see citing works

Cerebrospinal Fluid Biomarkers in Parkinson’s Disease: A Critical Overview of the Literature and Meta-Analyses

Katayama, T., Sawada, J., Takahashi, K., & Yahara, O. (2020) · Brain Sciences · doi:10.3390/brainsci10070466 · Cited by 48 · see citing works

Neurochemical biomarkers in the differential diagnosis of movement disorders

Mollenhauer, B., & Trenkwalder, C. (2009) · Movement Disorders · doi:10.1002/mds.22510 · Cited by 45 · see citing works

Targeting the Interplay Between Autophagy and the Nrf2 Pathway in Parkinson’s Disease with Potential Therapeutic Implications

Liu, M., Liu, S., Lin, Z.-H., Chen, X., Jiao, Q., Du, X., & Jiang, H. F. (2025) · Biomolecules · doi:10.3390/biom15010149 · Cited by 30 · see citing works

Increase in the Oxidized/Total Coenzyme Q-10 Ratio in the Cerebrospinal Fluid of Alzheimer’s Disease Patients

Isobe, C., Abe, T., & Terayama, Y. (2009) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000256209 · Cited by 29 · see citing works

Coenzyme Q10 and Parkinsonian Syndromes: A Systematic Review

Jiménez‐Jiménez, F. J., Alonso‐Navarro, H., García‐Martín, E., & Agúndez, J. A. G. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12060975 · Cited by 24 · see citing works

Biomarkers for trials of neuroprotection in Parkinson's disease

Agarwal, P. A., & Stoessl, A. J. (2012) · Movement Disorders · doi:10.1002/mds.25065 · Cited by 22 · see citing works

The role of biomarkers and imaging in Parkinson’s disease

Algarni, M., & Stoessl, A. J. (2015) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2016.1135056 · Cited by 17 · see citing works

A Diet for Dopaminergic Neurons?

Giovanni, G. D. (2009) · Springer eBooks · doi:10.1007/978-3-211-92660-4_27 · Cited by 12 · see citing works

Effect of dopaminergic neurotoxin MPTP/MPP+ on coenzyme Q content

Dhanasekaran, M., Karuppagounder, S. S., Uthayathas, S., Wold, L. E., Parameshwaran, K., Babu, R. J., Suppiramaniam, V. D., & Brown‐Borg, H. M. (2008) · Life Sciences · doi:10.1016/j.lfs.2008.04.016 · Cited by 10 · see citing works

Apport des biomarqueurs au diagnostic de la maladie de Parkinson

Lebouvier, T., Chaumette, T., Damier, P., Neunlist, M., & Derkinderen, P. (2008) · Bio Tribune Magazine · doi:10.1007/bf03001644

Biomarkers in Parkinson disease: studies on clinical, radiological and biological biomarkers

Crotty, G. F. (2018) · Arrow@dit (Dublin Institute of Technology)

Levels of reduced and oxidized coenzymeQ-10 and 8-hydroxy-2′-deoxyguanosine in the cerebrospinal fluid of patients with living Parkinson's disease demonstrate that mitochondrial oxidative damage and/or oxidative DNA damage contributes to the neurodegenerative process

Isobe, C., Abe, T., & Terayama, Y. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.11.065 · Cited by 130 · see citing works

Redox status of plasma coenzyme Q10 indicates elevated systemic oxidative stress in Parkinson's disease

Sohmiya, M., Tanaka, M., Wei Tak, N., Yanagisawa, M., Tanino, Y., Suzuki, Y., Okamoto, K., & Yamamoto, Y. (2004) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.05.007 · Cited by 143 · see citing works

Coenzyme Q10 and Parkinsonian Syndromes: A Systematic Review

Jiménez‐Jiménez, F. J., Alonso‐Navarro, H., García‐Martín, E., & Agúndez, J. A. G. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12060975 · Cited by 24 · see citing works

The coenzyme Q10 status of the brain regions of Parkinson’s disease patients

Hargreaves, I. P., Lane, A., & Abou‐Sleiman, P. M. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.09.069 · Cited by 56 · see citing works

Serum levels of coenzyme Q10 in patients with Parkinson's disease

Jiménez‐Jiménez, F. J., Molina, J. A., de Bustos, F., García‐Redondo, A., Gómez-Escalonilla, C., Martínez‐Salio, A., Berbel, Á., Camacho, A., Zurdo, M., Barcenilla, B., et al. (2000) · Journal of Neural Transmission · doi:10.1007/s007020050015 · Cited by 50 · see citing works